Viewing Study NCT00159120



Ignite Creation Date: 2024-05-05 @ 11:51 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00159120
Status: COMPLETED
Last Update Posted: 2008-01-30
First Post: 2005-09-07

Brief Title: Maintenance Treatment vs Stepwise Drug Discontinuation in First-Episode Schizophrenia
Sponsor: Heinrich-Heine University Duesseldorf
Organization: Heinrich-Heine University Duesseldorf

Study Overview

Official Title: Maintenance Treatment vs Stepwise Drug Discontinuation After One Year of Maintenance Treatment in First-Episode Schizophrenia
Status: COMPLETED
Status Verified Date: 2008-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: After one year neuroleptic maintenance treatment in patients with first episode schizophrenia neuroleptic treatment will be continued vs stepwise discontinued randomized design over a period of 1 year Under both conditions prodrome based early intervention take place
Detailed Description: After one year neuroleptic maintenance treatment in patients with first episode schizophrenia neuroleptic treatment will be continued vs stepwise discontinued randomized design over a period of 1 year Under both conditions pharmacologic early intervention strategies in case of early sign of relapse will be applied

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None